Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study.
van Boven N, Akkerhuis KM, Anroedh SS, Rizopoulos D, Pinto Y, Battes LC, Hillege HL, Caliskan KC, Germans T, Manintveld OC, Cornel JH, Constantinescu AA, Boersma E, Umans VA, Kardys I.
van Boven N, et al. Among authors: germans t.
Int J Cardiol. 2017 May 15;235:124-132. doi: 10.1016/j.ijcard.2017.02.078. Epub 2017 Feb 22.
Int J Cardiol. 2017.
PMID: 28274577
Free article.